$78.40
-$3.10(-3.80%)
*Data last updated: 2026-06-18 06:50 (UTC+8)
As of 2026-06-18 06:50, Medtronic plc (MDT) is priced at $78.40, with a total market cap of $100.32B, a P/E ratio of 22.24, and a dividend yield of 3.63%. Today, the stock price fluctuated between $73.64 and $81.85. The current price is 6.46% above the day's low and 4.21% below the day's high, with a trading volume of 8.29M. Over the past 52 weeks, MDT has traded between $71.97 to $91.55, and the current price is -14.36% away from the 52-week high.
MDT Key Stats
Yesterday's Close$81.32
Market Cap$100.32B
Volume8.29M
P/E Ratio22.24
Dividend Yield (TTM)3.63%
Dividend Amount$0.72
Diluted EPS (TTM)3.74
Net Income (FY)$4.80B
Revenue (FY)$36.36B
Earnings Date2026-08-18
EPS Estimate1.39
Revenue Estimate$9.55B
Shares Outstanding1.23B
Beta (1Y)0.597
Ex-Dividend Date2026-06-26
Dividend Payment Date2026-07-17
About MDT
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
SectorHealthcare
IndustryMedical - Devices
CEOGeoffrey Straub Martha
HeadquartersGalway,None,US
Official Websitehttps://www.medtronic.com
Employees (FY)95.00K
Average Revenue (1Y)$382.77K
Net Income per Employee$50.52K
Medtronic plc (MDT) FAQ
What's the stock price of Medtronic plc (MDT) today?
x
Medtronic plc (MDT) is currently trading at $78.40, with a 24h change of -3.80%. The 52-week trading range is $71.97–$91.55.
What are the 52-week high and low prices for Medtronic plc (MDT)?
x
What is the price-to-earnings (P/E) ratio of Medtronic plc (MDT)? What does it indicate?
x
What is the market cap of Medtronic plc (MDT)?
x
What is the most recent quarterly earnings per share (EPS) for Medtronic plc (MDT)?
x
Should you buy or sell Medtronic plc (MDT) now?
x
What factors can affect the stock price of Medtronic plc (MDT)?
x
How to buy Medtronic plc (MDT) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.







